Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Postgraduate Medical Journal 2008;84:217-219; doi:10.1136/pgmj.2007.065193
Copyright © 2008 The Fellowship of Postgraduate Medicine
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Srinivasan, M
Right arrow Articles by Smith, D
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srinivasan, M
Right arrow Articles by Smith, D

CASE REPORTS

Drug interaction with anti-mycobacterial treatment as a cause of clopidogrel resistance

M Srinivasan , D Smith

Department of Cardiology, Morriston Hospital, Swansea, Wales, UK

Correspondence to:
Dr M Srinivasan, Department of Cardiology, Morriston Hospital, Swansea SA 6 6NL, Wales, UK; smanivannan70{at}hotmail.com

The case is reported of a patient presenting with recurrent acute myocardial infarction due to stent thrombosis resulting from possible clopidogrel resistance caused by interaction between clopidogrel and anti-tuberculosis drugs. A brief overview of drug interaction as a risk factor for clopidogrel resistance is given.

Keywords: anti-mycobacterial therapy; clopidogrel resistance; cytochrome 450 3a; dual anti-platelet therapy; stent thrombosis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 The Fellowship of Postgraduate Medicine